Suchergebnisse - "Azijn, Hilde"

PubPharm (27)

1

Connection domain mutations in HIV-1 reverse transcriptase do not impact etravirine susceptibility and virologic responses to etravirine-containing regimens

enthalten in: Antimicrobial agents and chemotherapy | 2011

von Gupta, S. | Vingerhoets, J. | Fransen, S. | +11

2

Connection Domain Mutations in HIV-1 Reverse Transcriptase Do Not Impact Etravirine Susceptibility and Virologic Responses to Etravirine-Containing Regimens

enthalten in: Antimicrobial agents and chemotherapy | 2011

von Gupta, S. | Vingerhoets, J. | Fransen, S. | +11

3

Characterization of genotypic and phenotypic changes in HIV-1-infected patients with virologic failure on an etravirine-containing regimen in the DUET-1 and DUET-2 clinical studies

enthalten in: AIDS research and human retroviruses | 2010

von Tambuyzer, L. | Vingerhoets, J. | Azijn, H. | +4

4

Characterization of Genotypic and Phenotypic Changes in HIV-1-Infected Patients with Virologic Failure on an Etravirine-Containing Regimen in the DUET-1 and DUET-2 Clinical Studies

enthalten in: Aids research and human retroviruses | 2010

von Tambuyzer, L. | Vingerhoets, J. | Azijn, H. | +4

5

Short communication : activity of etravirine on different HIV type 1 subtypes: in vitro susceptibility in treatment-naive patients and week 48 pooled DUET study data

enthalten in: AIDS research and human retroviruses | 2010

von Vingerhoets, J. | Azijn, H. | Tambuyzer, L. | +7

6

Short Communication: Activity of Etravirine on Different HIV Type 1 Subtypes: In Vitro Susceptibility in Treatment-Naive Patients and Week 48 Pooled DUET Study Data

enthalten in: Aids research and human retroviruses | 2010

von Vingerhoets, J. | Azijn, H. | Tambuyzer, L. | +7

7

Etravirine limits the emergence of darunavir and other protease inhibitor resistance-associated mutations in the DUET trials

enthalten in: AIDS (London, England) | 2010

von Peeters, M. | Vingerhoets, J. | Tambuyzer, L. | +4

8

Resistance profile of etravirine : combined analysis of baseline genotypic and phenotypic data from the randomized, controlled Phase III clinical studies

enthalten in: AIDS (London, England) | 2010

von Vingerhoets, J. | Tambuyzer, L. | Azijn, H. | +7

9

TMC278, a next-generation nonnucleoside reverse transcriptase inhibitor (NNRTI), active against wild-type and NNRTI-resistant HIV-1

enthalten in: Antimicrobial agents and chemotherapy | 2010

von Azijn, H. | Tirry, I. | Vingerhoets, J. | +7

10

TMC278, a Next-Generation Nonnucleoside Reverse Transcriptase Inhibitor (NNRTI), Active against Wild-Type and NNRTI-Resistant HIV-1

enthalten in: Antimicrobial agents and chemotherapy | 2010

von Azijn, H. | Tirry, I. | Vingerhoets, J. | +7